Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Perimenopause: early-phase trial registry
4 of 7 indexed Perimenopause trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Perimenopause: 7 US clinical trials tracked, 4 recruiting.
Perimenopause is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Washington State University, running 2 of these trials.
Enrollment posture brief
Registry condition perimenopause
OPEN 4 | RECR 57% | LATE 1 | EARLY 3 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)
Perimenopause lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Perimenopause on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Perimenopause is recruiting above its size-band peers.
4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Perimenopause research.
Washington State University accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Perimenopause enrolment sits around 80 participants.
Median target enrolment is 80 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.
-
Perimenopause research is mostly interventional.
6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Effects of Hemp-Derived Cannabinoids on Menopause Symptoms
Washington State University
NCT07393672
Impact of Cannabinoids on Menopause Symptoms
Washington State University
NCT06831916
Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial
Mayo Clinic
NCT06826755
Hemodynamics After Resistance Training
University of Michigan
NCT07022340
Impact of Estradiol on Endothelial Function in Peri-Menopausal Women
University of Delaware
NCT04255160
Perimenopausal Estrogen Replacement Therapy Study
University of North Carolina, Chapel Hill
NCT01308814
Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure
National Eye Institute (NEI)
NCT00471731
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Perimenopause records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Perimenopause trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Perimenopause page
7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Perimenopause trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Washington State University sponsors the most Perimenopause trials on record, review their full trial history before evaluating a specific study. See Washington State University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Perimenopause condition card totals 7 registered trials; most-linked intervention Placebo; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.